Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

771500

	registered interest
	date	16/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the effect of the proposed requirement for clinical commissioning groups (CCGs) to go through an individual funding request before each patient is able to access bariatric surgery on (a) patient health and (b) capacity of CCGs to respond to that requirement.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	107834
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>There is no national requirement for clinical commissioning groups (CCGs) to go through an individual funding request process before each patient is able to access bariatric surgery. The implementation and operation of CCG commissioning policies is a matter for individual CCGs to determine.</p><p> </p><p>NHS England has therefore made no formal assessment of this proposed requirement on CCGs.</p><p> </p><p>The National Institute for Health and Care Excellence Clinical Guidelines 43 (updated November 2014) is clear about which groups of individuals bariatric surgery can benefit, with both clinical and cost effectiveness demonstrated, and attendance at Tier 3 services required first. Tier 3 covers multidisciplinary weight management services which are normally commissioned by CCGs.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/10/2017 10:09:30 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

769701

	registered interest
	date	12/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to eliminate Hepatitis C.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	107488
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>The United Kingdom government is a signatory to the World Health Assembly resolution and World Health Organization (WHO) goal of eliminating hepatitis C as a major public health threat by 2030.</p><p> </p><p>Progress towards achieving the WHO elimination goal is summarised in this year’s Public Health England’s (PHE) report “Hepatitis C in the UK”:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf</a></p><p>This showed that better access to improved treatment has led to the first fall in deaths from severe hepatitis C related liver disease in a decade and that the UK is on target for the WHO interim goal to reduce hepatitis C mortality by 10% by 2020.</p><p> </p><p>For England a sustainable rollout of access to new direct acting antivirals for treating chronic hepatitis C is underway with investment of in excess of £200 million per year. The current financial year (2017/18) is the third year of hepatitis C treatment ramp-up and the plan is to treat 12,500 individuals.</p><p> </p><p>An estimated 160,000 persons are believed to have hepatitis C in England. Further modelling work is being undertaken by PHE to update estimates of the impact of treatment roll out on prevalence of hepatitis C and hepatitis C-associated advanced liver disease. Previous PHE modelling of the scale up of treatment indicates that a “rapid complete coverage” scenario of treating 20,000 or more individuals per year and up to 50% of those infected each year would result in end-stage liver disease / hepatocellular cancer being halved within 10 years.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107489 question first answered 19/10/2017 15:17:27 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

769702

	registered interest
	date	12/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the number of people who require treatment each year to meet the UK's commitment to eliminate Hepatitis C as a public health concern by 2030.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	107489
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>The United Kingdom government is a signatory to the World Health Assembly resolution and World Health Organization (WHO) goal of eliminating hepatitis C as a major public health threat by 2030.</p><p> </p><p>Progress towards achieving the WHO elimination goal is summarised in this year’s Public Health England’s (PHE) report “Hepatitis C in the UK”:</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/632465/HCV_in_the_uk_report_2017.pdf</a></p><p>This showed that better access to improved treatment has led to the first fall in deaths from severe hepatitis C related liver disease in a decade and that the UK is on target for the WHO interim goal to reduce hepatitis C mortality by 10% by 2020.</p><p> </p><p>For England a sustainable rollout of access to new direct acting antivirals for treating chronic hepatitis C is underway with investment of in excess of £200 million per year. The current financial year (2017/18) is the third year of hepatitis C treatment ramp-up and the plan is to treat 12,500 individuals.</p><p> </p><p>An estimated 160,000 persons are believed to have hepatitis C in England. Further modelling work is being undertaken by PHE to update estimates of the impact of treatment roll out on prevalence of hepatitis C and hepatitis C-associated advanced liver disease. Previous PHE modelling of the scale up of treatment indicates that a “rapid complete coverage” scenario of treating 20,000 or more individuals per year and up to 50% of those infected each year would result in end-stage liver disease / hepatocellular cancer being halved within 10 years.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107488 question first answered 19/10/2017 15:17:27 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

769706

	registered interest
	date	12/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent discussions he has had with Cabinet colleagues on tackling childhood obesity.
	tabling member constituency	Stretford and Urmston
	tabling member printed	Kate Green
	uin	107445
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>My Rt. hon. Friend, the Secretary of State for Health, has not had any recent discussions with Cabinet colleagues on tackling childhood obesity. There are ongoing discussions between officials in the Department and other Government departments on delivering our childhood obesity plan.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/10/2017 15:18:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4120 label Biography information for Kate Green

768845

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Electronic Cigarettes: Advertising
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the advertising ban on the use of e-cigarettes.
	tabling member constituency	St Albans
	tabling member printed	Mrs Anne Main
	uin	107087
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107152 107154 107264 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
	tabling member	1568 label Biography information for Mrs Anne Main

768891

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether e-cigarettes can be promoted in public health campaigns under the Tobacco Products Directive.
	tabling member constituency	St Albans
	tabling member printed	Mrs Anne Main
	uin	107264
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107087 107152 107154 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
	tabling member	1568 label Biography information for Mrs Anne Main

768901

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Electronic Cigarettes: Advertising
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make it his policy to exclude e-cigarettes from the Tobacco Products Directive ban on advertising when the UK leaves the EU.
	tabling member constituency	St Albans
	tabling member printed	Mrs Anne Main
	uin	107152
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107087 107154 107264 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
	tabling member	1568 label Biography information for Mrs Anne Main

768983

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Electronic Cigarettes: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that public health campaigns are able to promote the use of e-cigarettes to aid smoking cessation.
	tabling member constituency	St Albans
	tabling member printed	Mrs Anne Main
	uin	107154
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>As announced in the England Tobacco Control Plan published 18 July 2017, the Department will monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our actions on regulating their use.</p><p> </p><p>Public Health England will continue to provide the evidence annually on e-cigarettes and other novel nicotine delivery systems until the end of Parliament in 2022 and will include within quit smoking campaign messages about the relative safety of e-cigarettes compared to smoking.</p><p> </p><p>The Department has published guidance on Article 20(5) of the EU Tobacco Products Directive covering restrictions on advertising electronic cigarettes. That guidance states that “a public health campaign about relative risks of e-cigarettes versus tobacco products by Public Health England or local stop smoking services are not advertisements made in the course of a business and therefore not covered by these restrictions”. The guidance is published here:</p><p><a href="https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete" target="_blank">https://www.gov.uk/government/publications/proposals-for-uk-law-on-the-advertising-of-e-cigarettes/publishing-20-may-not-yet-complete</a></p><p>The Government will review where the United Kingdom’s exit from the European Union offers opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government also has a statutory duty to conduct an implementation review of the Tobacco and Related Products Regulations 2016 by the end of May 2021 to assess its impact.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 107087 107152 107264 question first answered 19/10/2017 16:11:47 answering member 4067 label Biography information for Steve Brine
	tabling member	1568 label Biography information for Mrs Anne Main

769888

	registered interest
	date	12/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that people aged over 65 have adequate transport to and from routine hospital appointments.
	tabling member constituency	Redditch
	tabling member printed	Rachel Maclean
	uin	107561
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>Non-emergency patient transport services (PTS) are available for patients that meet certain criteria, including but not limited to those who are aged over 65 and satisfy one or more of the criteria outlined in the document Eligibility Criteria for Patient Transport Services.</p><p> </p><p>A patient’s eligibility for PTS should be determined either by a healthcare professional or by non-clinically qualified staff who are both clinically supervised and/or working within locally agreed protocols or guidelines, and employed by the National Health Service or working under contract for the NHS.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/10/2017 10:11:06 answering member 4067 label Biography information for Steve Brine
	tabling member	4668 label Biography information for Rachel Maclean

768962

	registered interest
	date	11/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes and Hypertension: Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to evolve Medicines Use Reviews to enable community pharmacists to better support people with long-term conditions such as diabetes and high blood pressure.
	tabling member constituency	Mid Derbyshire
	tabling member printed	Pauline Latham
	uin	107290
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>The Department is committed to supporting people with long term conditions manage their illness and take their medication correctly. In line with this ambition, eligibility for Medicine Use Reviews was amended from April 2015, to better target these services at patients who would derive the most benefit from it. This change required 70% of Medicine Use Reviews to be held with people within key target groups which included people with conditions such as diabetes or high blood pressure.</p><p> </p><p>The Department continues to develop and monitor the evidence base and effectiveness of all Advanced Services provided by community pharmacists to improve patient outcomes and make the best use of National Health Service resources. It will continue to do so and develop plans accordingly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/10/2017 16:24:21 answering member 4067 label Biography information for Steve Brine
	tabling member	4025 label Biography information for Mrs Pauline Latham